(Q35023517)

5 August 2017

title

Biopsy misidentification identified by DNA profiling in a large multicenter trial (English)

1 reference

multicenter clinical trial

5 August 2017

main subject

0 references

5

David G Bostwick

1 reference

5 August 2017

Michael Marberger

1

1 reference

5 August 2017

John D McConnell

2

1 reference

5 August 2017

Ivy Fowler

3

1 reference

5 August 2017

Gerald L Andriole

4

1 reference

5 August 2017

Matthew C Somerville

6

1 reference

5 August 2017

Roger S Rittmaster

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

28 March 2011

1 reference

Journal of Clinical Oncology

5 August 2017

published in

1 reference

5 August 2017

volume

29

1 reference

5 August 2017

issue

13

1 reference

5 August 2017

page(s)

1744-1749

1 reference

Effect of dutasteride on the risk of prostate cancer

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107764

Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107764

No residual cancer on radical prostatectomy after positive 10-core biopsy: incidence, biopsy findings, and DNA specimen identity analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107764

Increasing incidence of minimal residual cancer in radical prostatectomy specimens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107764

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107764

Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon".

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3107764

Little or no residual prostate cancer at radical prostatectomy: vanishing cancer or switched specimen?: a microsatellite analysis of specimen identity

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21444877

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Automated DNA profiling employing multiplex amplification of short tandem repeat loci

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21444877

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2010.32.1646

1 reference

5 August 2017

1 reference

5 August 2017

1 reference